The transitional phase of multiple sclerosis: Characterization and conceptual framework

Ingo Kleiter1, Ilya Ayzenberg2, Joachim Havla3

  • 1Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke, Berg, Germany; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.

Insights

The transition from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS) is gradual, not abrupt. Further research is needed to define this transitional MS phase and identify interventions to delay progression.

Area of Science:

  • Neuroimmunology
  • Clinical Neurology
  • Disease Progression

Background:

  • The conversion from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS) is a gradual process, lacking a defined threshold.
  • A transitional phase between RRMS and SPMS is hypothesized but poorly understood.
  • Current understanding of transitional multiple sclerosis (MS) lacks characterization of patient properties, disease course, and therapeutic strategies.

Purpose of the Study:

  • To review existing knowledge on the transitional phase of multiple sclerosis.
  • To characterize patient properties, disease course, and therapeutic interventions relevant to transitional MS.
  • To propose designs and criteria for a prospective clinical study in transitional MS patients.

Main Methods:

  • Literature review of current evidence on transitional MS.
  • Analysis of patient characteristics and disease progression in the transitional phase.
  • Exploration of potential diagnostic markers and therapeutic targets.

Main Results:

  • The conversion to SPMS is a continuum, suggesting a distinct transitional MS phase.
  • Transitional MS is poorly defined regarding clinical features, pathogenesis, and diagnostic markers.
  • Evidence for interventions delaying RRMS to SPMS conversion in this phase is limited.

Conclusions:

  • The transitional phase of MS requires further investigation to improve patient management.
  • Prospective studies are essential to define transitional MS and identify effective treatments.
  • Better characterization of transitional MS could lead to earlier diagnosis and intervention, potentially delaying disease progression.

Related Concept Videos

Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.4K
Marcia's Theory of Identity Status01:26

Marcia's Theory of Identity Status

James Marcia's identity status model provides a framework for understanding how adolescents navigate identity formation through varying degrees of exploration and commitment. Marcia's model builds on Erik Erikson's theories of psychosocial development, focusing specifically on how adolescents reconcile individual aspirations with societal expectations. His model describes identity formation as a dynamic process where adolescents move between different states depending on their level...
1.2K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.6K